$150 Million Class Action Settlement by Three Drug Makers
The nationalwide class action lawsuit, which accused TAP Pharmaceutical Products Inc., Abbott Laboratories and Takeda Pharmaceutical Co. Ltd., three drug makers of overcharging consumers for the prescription drug Lupron, wasb settled for $150 million.
The class bringing the lawsuit included all persons or health plans that purchased the drug from Jan. 1, 1985 until Dec. 31, 2004.
The lawsuit accused the three drug makers of engaging in a scheme to increase market share by inflating the average wholesale price of the drug, by providing free drugs to doctors and by instructing them how to bill insurers as if they had purchased the drugs.
Filed under Class Action, General Law, Settlements
You may also like to read
- $150 Million Class Action Settlement by Drug Makers
- Class Action Lawsuit Settlement for $70 Million by GlaxoSmithKline
- $10 Million Class Action Settlement against German Drugmaker Bayer
- $7.75 Million To Be Paid To Brooks Automation Under Securities Class Action Settlement
- $30 Million Class Action Lawsuit Settlement by Martha Stewart
- De Beers, World's No. 1 Diamond Supplier Agreed to Pay $250 Million in Price Fixing Settlement
- Five Drug Companies Will be Sued For Alleged Overcharging by South Carolina Attorney General
- 50$ Million Class Action Lawsuit Approved Against Pfizer
- GSK in Class Action Danger Over Anti-depressant Drug Seroxat
- Philadelphia based drug maker faces lawsuits
